ID
22296
Description
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Measurable Disease (Target Lesions) Assessment Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast
Lien
https://clinicaltrials.gov/ct2/show/NCT00078572
Mots-clés
Versions (1)
- 29/05/2017 29/05/2017 -
Téléchargé le
29 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Measurable Disease NCT00078572
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Measurable Disease NCT00078572
Description
Assessment 2
Alias
- UMLS CUI-1
- C1513041
- UMLS CUI-2
- C2986546
- UMLS CUI-3
- C0220825
Description
Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0221198
Description
Longest Diameter
Type de données
float
Unités de mesure
- mm
Alias
- UMLS CUI [1,1]
- C0552406
- UMLS CUI [1,2]
- C0221198
Description
Method
Type de données
text
Alias
- UMLS CUI [1,1]
- C0871511
- UMLS CUI [1,2]
- C0221198
Description
Lesion Status
Type de données
text
Alias
- UMLS CUI [1,1]
- C0449438
- UMLS CUI [1,2]
- C0221198
Similar models
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Measurable Disease NCT00078572
C2986546 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C0221198 (UMLS CUI [1,2])
C1710477 (UMLS CUI [2])
C0221198 (UMLS CUI [1,2])
C0450429 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C0450429 (UMLS CUI [2,2])
C0220825 (UMLS CUI [1,2])
C0221198 (UMLS CUI [1,3])
C0221198 (UMLS CUI [1,2])
C2986546 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C0220825 (UMLS CUI [1,2])
C0221198 (UMLS CUI [1,3])
C0221198 (UMLS CUI [1,2])
Aucun commentaire